viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia (original) (raw)

Nature Biotechnology volume 31, pages 545–552 (2013)Cite this article

Subjects

Abstract

New high-dimensional, single-cell technologies offer unprecedented resolution in the analysis of heterogeneous tissues. However, because these technologies can measure dozens of parameters simultaneously in individual cells, data interpretation can be challenging. Here we present viSNE, a tool that allows one to map high-dimensional cytometry data onto two dimensions, yet conserve the high-dimensional structure of the data. viSNE plots individual cells in a visual similar to a scatter plot, while using all pairwise distances in high dimension to determine each cell's location in the plot. We integrated mass cytometry with viSNE to map healthy and cancerous bone marrow samples. Healthy bone marrow automatically maps into a consistent shape, whereas leukemia samples map into malformed shapes that are distinct from healthy bone marrow and from each other. We also use viSNE and mass cytometry to compare leukemia diagnosis and relapse samples, and to identify a rare leukemia population reminiscent of minimal residual disease. viSNE can be applied to any multi-dimensional single-cell technology.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Bendall, S.C. et al. A deep profiler's guide to cytometry. Trends Immunol. 33, 323–332 (2012).
    Article CAS PubMed PubMed Central Google Scholar
  2. Petilla Interneuron Nomenclature Group. et al. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat. Rev. Neurosci. 9, 557–568 (2008).
  3. Irish, J.M. et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118, 217–228 (2004).
    Article CAS PubMed Google Scholar
  4. Sachs, K. et al. Causal protein-signaling networks derived from multiparameter single-cell data. Science 308, 523–529 (2005).
    Article CAS PubMed Google Scholar
  5. Majeti, R., Park, C.Y. & Weissman, I.L. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1, 635–645 (2007).
    Article CAS PubMed PubMed Central Google Scholar
  6. Tarnok, A., Ulrich, H. & Bocsi, J. Phenotypes of stem cells from diverse origin. Cytometry A 77, 6–10 (2010).
    Article PubMed Google Scholar
  7. O'Brien, C.A., Kreso, A. & Dick, J.E. Cancer stem cells in solid tumors: an overview. Semin. Radiat. Oncol. 19, 71–77 (2009).
    Article PubMed Google Scholar
  8. Bandura, D.R. et al. Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal. Chem. 81, 6813–6822 (2009).
    Article CAS PubMed Google Scholar
  9. Cornett, D.S. et al. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat. Methods 4, 828–833 (2007).
    Article CAS PubMed Google Scholar
  10. Mercer, J. et al. RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection. Cell Rep. 2, 1036–1047 (2012).
    Article CAS PubMed Google Scholar
  11. Ozsolak, F. & Milos, P.M. RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 12, 87–98 (2011).
    Article CAS PubMed Google Scholar
  12. Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57–63 (2009).
    Article CAS PubMed PubMed Central Google Scholar
  13. Dalerba, P. et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat. Biotechnol. 29, 1120–1127 (2011).
    Article CAS PubMed PubMed Central Google Scholar
  14. Lubeck, E. & Cai, L. Single-cell systems biology by super-resolution imaging and combinatorial labeling. Nat. Methods 9, 743–748 (2012).
    Article CAS PubMed PubMed Central Google Scholar
  15. Benoist, C. & Hacohen, N. Immunology. Flow cytometry, amped up. Science 332, 677–678 (2011).
    Article CAS PubMed Google Scholar
  16. Bendall, S.C. & Nolan, G.P. From single cells to deep phenotypes in cancer. Nat. Biotechnol. 30, 639–647 (2012).
    Article CAS PubMed Google Scholar
  17. Herzenberg, L.A. et al. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7, 681–685 (2006).
    Article CAS PubMed Google Scholar
  18. Qiu, P. et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat. Biotechnol. 29, 886–891 (2011).
    Article CAS PubMed PubMed Central Google Scholar
  19. Qian, Y. et al. Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin. Cytom. 78 (suppl. 1), S69–S82 (2010).
    Article PubMed PubMed Central Google Scholar
  20. Pyne, S. et al. Automated high-dimensional flow cytometric data analysis. Proc. Natl. Acad. Sci. USA 106, 8519–8524 (2009).
    Article CAS PubMed PubMed Central Google Scholar
  21. Bendall, S.C. et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687–696 (2011).
    CAS PubMed PubMed Central Google Scholar
  22. Van der Maaten, L. & Hinton, G. Visualizing (2579–2605): data using t-SNE. J. Mach. Learn. Res. 9, 2579–2605 (2008).
    Google Scholar
  23. Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21, 759–806 (2003).
    Article CAS PubMed Google Scholar
  24. van Lochem, E.G. et al. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry B Clin. Cytom. 60, 1–13 (2004).
    Article CAS PubMed Google Scholar
  25. Wakita, S. et al. Mutations of the epigenetics modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia. Leukemia published online doi: 10.1038/leu.2012.317 (8 November 2012).
  26. Campana, D. Status of minimal residual disease testing in childhood haematological malignancies. Br. J. Haematol. 143, 481–489 (2008).
    PubMed PubMed Central Google Scholar
  27. Borowitz, M.J. et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 111, 5477–5485 (2008).
    Article CAS PubMed PubMed Central Google Scholar
  28. Ossenkoppele, G.J., van de Loosdrecht, A.A. & Schuurhuis, G.J. Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms. Br. J. Haematol. 153, 421–436 (2011).
    Article CAS PubMed Google Scholar
  29. Loken, M.R. et al. Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group. Blood 120, 1581–1588 (2012).
    Article PubMed PubMed Central Google Scholar
  30. Bodenmiller, B. et al. Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat. Biotechnol. 30, 858–867 (2012).
    Article CAS PubMed PubMed Central Google Scholar
  31. Van der Maaten, L., Postma, E. & Van Den Herik, H. Dimensionality reduction: A comparative review. J. Mach. Learn. Res. 10, 1–41 (2009).
    Google Scholar
  32. Blondel, V.D. et al. Fast unfolding of communities in large networks. J. Stat. Mech. 2008, P10008 (2008).
    Article Google Scholar
  33. Kotecha, N., Krutzik, P.O. & Irish, J.M. Web-based analysis and publication of flow cytometry experiments. Curr. Protoc. Cytom. 10, 10.17 (2010).
    Google Scholar

Download references

Acknowledgements

The authors would like to thank N. Friedman, I. Pe'er and O. Litvin for valuable comments. The authors would also like to thank M. Minden (Princess Margaret Hospital), C. Mullighan, J. Downing and I. Radtke (St. Jude Children's Hospital) for generously providing leukemia samples for mass cytometry analysis. This research was supported by the National Science Foundation CAREER award through grant number MCB-1149728, National Institutes of Health Roadmap Initiative, NIH Director's New Innovator Award Program through grant number 1-DP2-OD002414-01 and National Centers for Biomedical Computing Grant 1U54CA121852-01A1. E.D.A. is a Howard Hughes Medical Institute International Student Research Fellow. K.L.D. is supported by Alex's Lemonade Fund Young Investigator Award and St. Baldrick's Foundation Scholar Award. S.C.B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09). G.P.N. is supported by the Rachford and Carlota A. Harris Endowed Professorship and grants from U19 AI057229, P01 CA034233, HHSN272200700038C, 1R01CA130826, CIRM DR1-01477 and RB2-01592, NCI RFA CA 09-011, NHLBIHV-10-05(2), European Commission HEALTH.2010.1.2-1, and the Bill and Melinda Gates Foundation (GF12141-137101). D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering.

Author information

Author notes

  1. Kara L Davis, Michelle D Tadmor, Erin F Simonds, Jacob H Levine, Sean C Bendall and Daniel K Shenfeld: These authors contributed equally to this work.
  2. Garry P Nolan and Dana Pe'er: These authors jointly directed this work.

Authors and Affiliations

  1. Department of Biological Sciences, Columbia Initiative for Systems Biology, Columbia University, New York, New York, USA
    El-ad David Amir, Michelle D Tadmor, Jacob H Levine, Daniel K Shenfeld, Smita Krishnaswamy & Dana Pe'er
  2. Department of Microbiology and Immunology, Baxter Laboratory in Stem Cell Biology, Stanford University, Stanford, California, USA
    Kara L Davis, Erin F Simonds, Sean C Bendall & Garry P Nolan

Authors

  1. El-ad David Amir
    You can also search for this author inPubMed Google Scholar
  2. Kara L Davis
    You can also search for this author inPubMed Google Scholar
  3. Michelle D Tadmor
    You can also search for this author inPubMed Google Scholar
  4. Erin F Simonds
    You can also search for this author inPubMed Google Scholar
  5. Jacob H Levine
    You can also search for this author inPubMed Google Scholar
  6. Sean C Bendall
    You can also search for this author inPubMed Google Scholar
  7. Daniel K Shenfeld
    You can also search for this author inPubMed Google Scholar
  8. Smita Krishnaswamy
    You can also search for this author inPubMed Google Scholar
  9. Garry P Nolan
    You can also search for this author inPubMed Google Scholar
  10. Dana Pe'er
    You can also search for this author inPubMed Google Scholar

Contributions

E.D.A., G.P.N. and D.P. conceived the study. E.D.A. and D.P. developed the methods. D.K.S. and M.D.T. implemented parallel t-SNE and cyt, respectively. E.F.S., S.C.B., K.L.D. and G.P.N. designed and performed mass and flow cytometry experiments. E.D.A., J.H.L., E.F.S., S.C.B., K.L.D., S.K. and D.P. performed the biological analysis and interpretation. E.D.A. and M.D.T. performed robustness analysis of the method. E.D.A., J.H.L., K.L.D., E.F.S. and D.P. wrote the manuscript.

Corresponding author

Correspondence toDana Pe'er.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Amir, Ea., Davis, K., Tadmor, M. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia.Nat Biotechnol 31, 545–552 (2013). https://doi.org/10.1038/nbt.2594

Download citation

This article is cited by

Associated content